bluebird bio today announced the successful completion of a $60 million Series D financing. bluebird bio today announced the successful completion of a $60 million Series D financing.
Tags: Third Rock Ventures
NinePoint Medical Inc secures $34M in Series B funding round
Corning Inc led the $34 million Series B funding round for Cambridge, Massachusetts-based medical device maker NinePoint Medical Inc, a statement about the funding said.
Biopharmaceutical firm Igenica Inc nabs additional $14M in Series C extension funding
Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.
Cambridge fat-burning drug maker Zafgen nabs USD45 million in Series E funding
Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.
Biotech venture capital firms invest USD43 million in Series A funding in Editas Medicine
A consortium of venture capitalists had helped Editas Medicine raised USD43 million in Series A financing to create medicine designed to eradicate gene abnormalities.
Latest News
1
